Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

SHBG may be a useful early indicator and treatment target for PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

PRP treatment helps hair growth in most cases, but more research needed.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Jojoba oil is highly valued for its diverse medicinal and industrial uses.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.